Clinical Trial Update: A Study Assessing HMB-002 in Participants With Von Willebrand Disease [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update notes a Phase 1/2 study of the investigational agent HMB-002 for Von Willebrand disease. The trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Von Willebrand Disease

Drugs mentioned

• HMB-002

Snippet

Sponsor: Hemab ApS | Conditions: Von Willebrand Disease (VWD), Von Willebrand Disease (VWD), Type 1 | Phase 1, Phase 2 | Status: RECRUITING